D. Boral Capital Maintains Buy on Coya Therapeutics, Maintains $15 Price Target

Coya Therapeutics, Inc. -4.67%

Coya Therapeutics, Inc.

COYA

4.68

-4.67%

D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ: COYA) with a Buy and maintains $15 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via